S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

OpenEvidence Introduces Real-Time Grading for Medical AI Citations

A randomized, blinded clinical trial carries vastly more weight than a small observational study, yet medical AI often treats them as equals. Miami-based OpenEvidence aims to bridge this gap with EvidenceGrade, a new tool that automatically quantifies and displays the reliability of scientific sources behind every AI-generated clinical response.

OpenEvidence Introduces Real-Time Grading for Medical AI Citations
Photo: Bio & News

The platform, which is widely utilized by U.S. physicians, developed this feature to address the critical lack of transparency in how AI synthesizes medical literature. By applying a methodology derived from the GRADE framework—the same standard utilized by the World Health Organization and Cochrane—the system provides clinicians with an immediate assessment of the evidence strength supporting a specific treatment decision. This allows practitioners to distinguish between high-certainty data and anecdotal reports at the point of care.

Samuel Finlayson, Senior Vice President of Medical AI at OpenEvidence, noted that while traditional research appraisal teams provide invaluable insights, they cannot address every question encountered in daily practice. EvidenceGrade functions as a scalable extension of these rigorous methods. The tool complements existing partnerships with organizations like the American Academy of Otolaryngology–Head and Neck Surgery Foundation, aiming to provide structured, transparent evaluations even for clinical questions that currently lack formal systematic reviews.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!